CLDN6 CAR-T cell therapy of relapsed/refractory solid tumors ± a CLDN6-encoding mRNA vaccine: Dose escalation data from the BNT211-01 phase 1 trial using an automated product

Mackensen, Andreas and Haanen, John B. A. G. and Koenecke, Christian and Alsdorf, Winfried and Wagner-Drouet, Eva Maria and Heudobler, Daniel and Borchmann, Peter and Bokemeyer, Carsten and Klobuch, Sebastian and Kutsch, Nadine and Mueller, Fabian and Desuki, Alexander and Lueke, Florian and Wiegert, Erol and Flemmig, Carina and Schulz-Eying, Catrine and Rengstl, Benjamin and Preussner, Liane and Tuereci, Oezlem and Sahin, Ugur (2023) CLDN6 CAR-T cell therapy of relapsed/refractory solid tumors ± a CLDN6-encoding mRNA vaccine: Dose escalation data from the BNT211-01 phase 1 trial using an automated product. In: Annual Meeting of the American Society of Clinical Oncology (ASCO), June 02-06, 2023, Chicago, IL.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Poster)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User:	Dr. Gernot Deinzer
Date Deposited:	08 Mar 2024 10:19
Last Modified:	08 Mar 2024 10:19
URI:	https://pred.uni-regensburg.de/id/eprint/60294

Actions (login required)

View Item